The Stanford School of Medicine, the Division of Oncology, and the Stanford Cancer Institute present:
The Cancer Education Seminar Series
Topic: Endocrinology/GI/ Genetics
Title: “TBA”
Presenter: Carolyn Dacey Seib, MD, MAS, FACS
The Stanford School of Medicine, the Division of Oncology, and the Stanford Cancer Institute present:
The Cancer Education Seminar Series
Topic: Endocrinology/GI/ Genetics
Title: “TBA”
Presenter: Justin Annas, MD, PhD
The Stanford School of Medicine, the Division of Oncology, and the Stanford Cancer Institute present:
The Cancer Education Seminar Series
Topic: Endocrinology/GI/ Genetics
Title: “TBA”
Presenter: Brandan Visser, MD
Presenter:
Alyce S. Adams, PhD
Alyce S. Adams is a Research Scientist III, Associate Director, Health Care Delivery and Policy, and Director of Faculty Development at the Kaiser Permanente Division of Research in Oakland, California. Focusing on healthcare disparities, her interdisciplinary research examines suboptimal treatment outcomes among older adults with chronic conditions.
Join us on Zoom: https://bit.ly/3dvYuzf Password: 383676
Tanja Gruber, MD, PhD is the Division Chief of Pediatric Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine and Director of the Bass Center for Cancer and Blood Disorders. She is a product of the University of Washington, with dual BS degrees in Biology and Biochemistry; University of Southern California, there with MD in Medicine and PhD in Immunology; and Children’s Hospital of Los Angeles for Internship and Residency in Pediatrics and then Fellowship in Hematology and Oncology. Dr. Gruber was recruited after fellowship to St. Jude Children’s Research Hospital, where she became a nationally and internationally recognized physician- scientist. At St. Jude she focused on high-risk leukemia and acute megakaryoblastic leukemia (AMKL). Her laboratory research has led to the identification of CBFA2T3-GLIS2, a novel fusion gene that confers a poor prognosis in pediatric AMKL, and a detailed view of the genomic landscape in MLLr leukemia.
Join us on Zoom: https://bit.ly/2ZLtI1S Password: 576948
Presenter:
Michael Lim, MD
Dr. Michael Lim is Professor and Chair of Neurosurgery at Stanford University School of Medicine. Dr. Lim obtained his medical degree from the Johns Hopkins University School of Medicine. He then completed his residency in Neurosurgery at Stanford and went on to become a Professor of Neurosurgery, Oncology and Radiation Oncology at Johns Hopkins before returning to Stanford. Dr. Lim’s surgical interest is in both benign and malignant brain tumors, with a particular interest in gliomas (including ependymoma), meningioma, pituitary tumors and skull base tumors. He has extensive experience in new and innovative neurosurgical techniques including image guided surgery, microsurgery, minimally invasive procedures and endoscopic surgery.
Dr. Lim’s primary research interest is developing immune-based therapies against brain tumors. His research laboratory is focused on understanding the mechanisms of immune evasion by primary brain tumors. Findings from his laboratory are directed towards translation to novel therapies against brain tumors. He currently serves as the principal investigator of several large brain tumor immunotherapy clinical trials based on findings from his laboratory.
Join us on Zoom: https://bit.ly/3jCFPp0 Password: 950369
From Intern to Chief: A Tale of Partnerships and Persistence with a Vision for the Future
Dr. Heather Wakelee is a Professor of Medicine in the Division of Oncology at Stanford University and is the faculty director of the Stanford Cancer Clinical Trials Office. Dr. Wakelee has authored or co-authored over 200 medical articles on lung cancer and other thoracic malignancies and is involved in dozens of clinical trials related to lung cancer therapy and diagnostics. Her research focuses on many specific lung cancer subtypes defined by specific mutations in EGFR, ALK, ROS1, RET, BRAF and others. She is also involved in trials of adjuvant therapy, immunotherapy and anti-angiogenesis agents in addition to collaborations with colleagues focused in biomarkers and others focused in population science research.
Dr. Wakelee is active in multiple national and international lung cancer research organizations including serving as a member of the Board of Directors of the International Association for the Study of Lung Cancer (IASLC), co-chair of the thoracic committee and Stanford Principal Investigator for the Eastern Cooperative Oncology Group (ECOG-ACRIN), and as a Fellow of the American Society of Clinical Oncology (FASCO).
Join us on Zoom: http://bit.ly/FIOWakelee Password: 383676
Thursday, October 29, 2020 3:30 PM – 5:00 PM, Zoom Link provided upon registration
Join Stanford Cancer Institute | Community Outreach & Engagement for a town hall designed for the local and regional community to provide education about the impact of COVID-19 and cancer.
Topics will include:
- Cancer Screening and Prevention
- Cancer Patients and Survivors
- Cancer Patient Finances
Questions can be submitted in advance here or live during the Town Hall
Our featured speakers are:
- Lisa Goldman Rosas, PhD, MPH (Moderator), Epidemiologist, Stanford Medicine
- Melissa Bondy, PhD, Epidemiologist, Stanford Medicine
- Elwyn Cabebe, MD, Medical Oncologist, University Health Care Alliance
- Steve O’Brien, MD, Chief Medical Officer, Alameda Alliance for Health
- Lidia Schapira, MD, Medical Oncologist, Stanford Medicine
Co-Sponsored by:
Stanford Cancer Institute Community Outreach and Engagement and
Stanford Medicine Office of Community Engagement
Presenter: Dr. Manali I. Patel, MD
Click HERE to Register!
The mission of the Stanford Center for Clinical Research (SCCR) includes offering educational resources, training, and support for investigators and research staff. We have invited the Assistant Professor of Medicine in Oncology, Dr. Manali I. Patel, MD, to provide you with the principles of oncology and treatments. The speaker will review etiologies and determinants for disparities. She will also review research areas including delivery science and its application to care delivery for patients with oncologic diseases.
At the conclusion of this class, you will be able to:
- Apply principles of Cancer Epidemiology
- Examine Screening Policies and Implications for Cancer
- Explain principles of ZNA as etiologies for disparities in cancer development and outcomes
- Analyze barriers that lead to disparities across the cancer continuum
- Apply strategies to overcome barriers in current cancer care delivery
Attendance is open to all research staff.
About the Instructors:
Dr. Manali I. Patel, MD, is a medical thoracic oncologist and health services researcher at the Stanford University School of Medicine and the Veterans Affairs Palo Alto Health Care System. She obtained her MD and Masters in Public Health at UNC-Chapel Hill and completed her Internal Medicine residency, fellowship in Hematology and Oncology, and Masters in Science in Health Services Research at Stanford University. Dr. Patel’s research involves evaluating systems-level and social factors that influence disparities in cancer and value-based care delivery. Her expertise lies in designing, implementing, and evaluating new models of cancer care delivery with academic, community, and VA oncology practices aimed to improve patient experiences with care, clinical outcomes, and reduce unwanted healthcare utilization and health disparities. Dr. Patel also has expertise in linking large cancer registries to investigate modifiable etiologies for disparate care receipt among populations.
BRN OPTIONAL
Spectrum is an approved provider by the California Board of Registered Nursing, Provider Number CEP15435 for 2 contact hour(s).
To receive your certificate with BRN credit, you are required to complete an evaluation at the conclusion of this class.
BRN Cancellation Policy: If you wish to cancel your registration, please contact the course coordinators, Susan Saba, ssaba@stanford.edu.